Technical Analysis for OGEN - Oragenics, Inc.

Grade Last Price % Change Price Change
grade C 0.5264 -4.88% -0.03
OGEN closed down 4.88 percent on Friday, February 14, 2020, on 82 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical OGEN trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
50 DMA Support Bullish -4.88%
Wide Bands Range Expansion -4.88%
50 DMA Support Bullish 3.22%
1,2,3 Pullback Bullish Bullish Swing Setup 3.22%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.22%
Upper Bollinger Band Walk Strength 3.22%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.
Medicine Health Healthcare Health Care Antibiotics Antibiotic Healthcare Associated Infections Bacteriology Digestive System Oral Hygiene Tooth Whitening

Is OGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.99
52 Week Low 0.35
Average Volume 901,048
200-Day Moving Average 0.48
50-Day Moving Average 0.50
20-Day Moving Average 0.49
10-Day Moving Average 0.52
Average True Range 0.05
ADX 36.8
+DI 37.45
-DI 8.75
Chandelier Exit (Long, 3 ATRs ) 0.61
Chandelier Exit (Short, 3 ATRs ) 0.58
Upper Bollinger Band 0.60
Lower Bollinger Band 0.37
Percent B (%b) 0.69
BandWidth 45.56
MACD Line 0.02
MACD Signal Line 0.01
MACD Histogram 0.0093
Fundamentals Value
Market Cap 25.93 Million
Num Shares 49.3 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -3.31
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.58
Resistance 3 (R3) 0.58 0.57 0.57
Resistance 2 (R2) 0.57 0.55 0.56 0.57
Resistance 1 (R1) 0.55 0.55 0.54 0.54 0.56
Pivot Point 0.53 0.53 0.53 0.53 0.53
Support 1 (S1) 0.51 0.52 0.51 0.51 0.49
Support 2 (S2) 0.50 0.51 0.50 0.49
Support 3 (S3) 0.48 0.50 0.48
Support 4 (S4) 0.48